Foens C S, Hussey D H, Staples J J, Doornbos J F, Wen B C, Vigliotti A P
Department of Radiology, University of Iowa College of Medicine, Iowa City.
Int J Radiat Oncol Biol Phys. 1991 Sep;21(4):961-8. doi: 10.1016/0360-3016(91)90736-n.
Between 1939 and 1986, 42 patients with carcinoma of the female urethra were treated with surgery and/or radiation therapy at the University of Iowa. Ten patients were treated with surgery alone, 28 with radiation therapy alone, and 4 with combined surgery and radiation therapy. Seventeen patients (40%) developed persistent or recurrent disease at the primary site and 15 (36%) had failures in the inguinal nodes. The actuarial 5-year survival rate was 33.5%. Only 36% (10/28) of patients treated with radiation therapy had local failures, compared to 60% (6/10) of those treated with surgery alone. The best results were achieved with combined interstitial and external beam irradiation. Whereas 57% (8/14) of patients who were treated with combined interstitial and external beam irradiation were alive NED at 3 years, none of 7 patients (0%) treated with interstitial implants only and 2 of 7 patients (29%) treated with external beam irradiation alone were alive NED at 3 years. There was a significantly lower inguinal failure rate in patients who received treatment to the inguinal nodes (10%) than in those who did not receive inguinal area treatment (52%), and this translated into a superior 5-year survival for those patients (60% vs 18%). Survival rates did not correlate with histopathologic type in this series, although there were differences in the patterns of failure. Survival rates did correlate well with clinical stage.
1939年至1986年间,爱荷华大学对42例女性尿道癌患者进行了手术和/或放射治疗。10例患者仅接受手术治疗,28例仅接受放射治疗,4例接受手术与放射联合治疗。17例患者(40%)在原发部位出现持续性或复发性疾病,15例(36%)腹股沟淋巴结出现转移。5年精算生存率为33.5%。仅接受放射治疗的患者中,36%(10/28)出现局部复发,而仅接受手术治疗的患者中这一比例为60%(6/10)。间质内照射与外照射联合治疗效果最佳。接受间质内照射与外照射联合治疗的患者中,57%(8/14)在3年时无疾病生存,仅接受间质植入治疗的7例患者中无一人(0%)在3年时无疾病生存,仅接受外照射治疗的7例患者中有2例(29%)在3年时无疾病生存。接受腹股沟淋巴结治疗的患者腹股沟转移率(10%)显著低于未接受腹股沟区治疗的患者(52%),这使得这些患者的5年生存率更高(60%对18%)。尽管在复发模式上存在差异,但本系列患者的生存率与组织病理学类型无关。生存率与临床分期密切相关。